Rho site logo

[Webinar] Development Advice for Gene Therapy Products

October 24, 2018 - 1:00pm to 2:00pm
Share:

It has been and big year for gene therapy.  In the past 12 months, three gene therapy products received approval from FDA, and in July 2018, FDA Commissioner Scott Gottlieb released a statement on the FDA’s efforts and commitment to advance gene therapy.  The statement included the announcement of six new or revised guidance documents related to the development of gene therapy products.  This webinar will review Commissioner Gottlieb’s statement, provide an overview of the six guidance documents, and discuss the implications for development of new gene therapy products from the perspective of regulatory strategy, clinical development, pharmacology/toxicology considerations, and CMC development.

 

Register here!